Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of... Read More

Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effica... Read More

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascendi... Read More

Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... Read More

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More

Karnataka CM Siddaramaiah holds closed door talks amid signs of power transition to DKS

India, May 28 -- Senior ministers in the Karnataka government gathered at chief minister Siddaramaiah's official residence on Thursday morning amid growing indications that the party was moving toward... Read More

Bengaluru-Bhubaneswar flight diverted to Lucknow due to Kalbaisakhi weather

Bhubaneswar, May 28 -- A Bengaluru-Bhubaneswar domestic flight was diverted to Lucknow on Wednesday after adverse weather conditions triggered by Kalbaisakhi rain prevented the aircraft from landing a... Read More

कर्मचारियों को झटका! 8वें वेतन आयोग से बड़ी सैलरी बढ़ोतरी की उम्मीद कम क्यों? सरकार अपना सकती है 'मिडिल पाथ'

नई दिल्ली, मई 28 -- 8वें वेतन आयोग को लेकर देशभर के लाखों केंद्रीय कर्मचारी और पेंशनर्स बेसब्री से इंतजार कर रहे हैं। हर तरफ यही चर्चा है कि इस बार सैलरी में कितना बड़ा इजाफा होगा और क्या कर्मचारियों ... Read More

बीएचयू हॉस्टल में सब्जी में निकली मरी छिपकली, छात्र आक्रोशित, बंद कराया मेस

नई दिल्ली, मई 28 -- UP News: काशी हिंदू विश्वविद्यालय (बीएचयू) के डालमिया हॉस्टल से छात्रों की सेहत से खिलवाड़ का एक बेहद गंभीर मामला सामने आया है। यहां हॉस्टल के मेस में छात्रों को परोसी गई सब्जी में... Read More

Clinical Trial: A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609719) titled 'A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis W... Read More

• ««
• «
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• 45
• 46
• 47
• »
• »»